17β-oestradiol treatment modulates nitric oxide synthase activity in mda231 tumour with implications on growth and radiation response

British Journal of Cancer

Volumn 86, Issue 1, 2002, Pages 136-142

  Chinje, E C ^a   Williams, K J ^a   Telfer, B A ^a   Wood, P J ^b   Van der Kogel, A J ^c   Stratford, I J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b University of Bath   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

17 oestradiol; Breast tumour; Hypoxia; Nitric oxide synthase; Radiation response

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL HYPOXIA; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER RADIOTHERAPY; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE LOCATION; HUMAN CELL; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RADIATION RESPONSE; TREATMENT OUTCOME;

BREAST NEOPLASMS; CELL HYPOXIA; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0037033141     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600032     Document Type: Article

References (48)

1. Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature
2. Chemotherapy of human breast carcinoma xenografts
3. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts
4. Apoptosis and disease
5. Expression of nitric oxide synthase in human central nervous system tumors
6. Estrogen receptors alpha and beta: Two receptors of a kind?
7. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma
8. Lack of correlation between natural killer cell activity and tumor growth control in nude mice with different immune defects
9. Angiogenesis in cancer, vascular, rheumatoid and other disease
10. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice
11. Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss
12. Expression of wild-type estrogen receptor β and variant isoforms in human breast cancer
13. Identification of a chemoattractant for fibroblasts produced by human breast carcinoma cell lines
14. Natural killer cells as antitumor effector cells
15. Effect of nitric oxide on the radiosensitivity of bacteria
16. Roles of nitric oxide in tumour growth
17. Nitrogen oxide-induced auto-protection in isolated rat hepatocytes
18. The therapeutic response of three human tumour lines maintained in immuno-suppressed mice
19. Metastatic behaviour of human tumor cell lines grown in the nude mouse
20. Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis
21. Expression of estrogen receptor β1, β2, and β5 messenger RNAs in human breast tissue
22. Role of nitric oxide in the control of apoptosis in the microvasculature
23. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
24. Pathogenesis of cancer in view of mutually opposing apoptotic and anti-apoptotic growth signals
25. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
26. Hypoxic mammalian cell radiosensitization by nitric oxide
27. Nitric oxide as a secretory product of mammalian cells
28. Commentary on human mammary preneoplasia. The estrogen receptor-promotion hypothesis
29. Hypoxia response elements
30. Differential expression of estrogen receptor-α and -β messenger RNAs as a potential marker of ovarian carcinogenesis
31. Beta-estradiol reduces natural killer cells in mice
32. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice
33. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromise resistance to tumor metastasis in rats
34. Tumor biology
35. Role of NK cells in tumour growth and metastasis in beige mice
36. Nitric oxide synthase activity in human gynaecological cancer
37. Nitric oxide synthase activity in human breast cancer
38. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor
39. Multiple hormone interactions in the developmental biology, of the mammary gland
40. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells
41. Expression of estrogen receptor β messenger RNA variant in breast cancer
42. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines
43. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma
44. Induction of calcium-dependent nitric oxide by sex hormones
45. g-nitro-L-arginine
46. Modification of energy metabolism in transplantable and spontaneous tumors by the nitric oxide synthase inhibitor nitro-L-arginine
47. Analysis of insulin-like growth factor gene expression in malignancy: Evidence for a paracrine role in human breast cancer